VanEck Bionic Financials
| CYBO Etf | 21.56 0.10 0.47% |
VanEck |
The data published in VanEck Bionic's official financial statements typically reflect VanEck Bionic's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving VanEck Bionic's quantitative information. For example, before you start analyzing numbers published by VanEck accountants, it's essential to understand VanEck Bionic's liquidity, profitability, and earnings quality within the context of the VanEck space in which it operates.
Please note, the imprecision that can be found in VanEck Bionic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VanEck Bionic Engineering. Check VanEck Bionic's Beneish M Score to see the likelihood of VanEck Bionic's management manipulating its earnings.
VanEck Bionic November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VanEck Bionic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VanEck Bionic Engineering. We use our internally-developed statistical techniques to arrive at the intrinsic value of VanEck Bionic Engineering based on widely used predictive technical indicators. In general, we focus on analyzing VanEck Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VanEck Bionic's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.7693 | |||
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 3.61 | |||
| Value At Risk | (1.19) | |||
| Potential Upside | 1.52 |